ENTX
Entera Bio Ltd.
Latest Form 4:Purchase$26KbyGermano Geno J (Director) · filed Mar 11, 2026
Entera Bio Ltd. (ENTX) has 13 SEC Form 4 filings (14 transaction rows) in the rolling window, disclosed by 3 distinct insiders. Most recent filing: Aug 7, 2026.
Insiders have net bought $102K over the trailing 6 months.
- Industry:Biotechnology
- CEO:Miranda J. Toledano
- Employees:22
- HQ:Jerusalem, JM, IL
- IPO:2018-06-28
Insider Buying
$102K
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Unique Insiders
3
in the rolling window
Market Cap
$147.7M
latest known value
| Source | ||||||
|---|---|---|---|---|---|---|
| Director | Purchase | 20,000 | $26K | Mar 11 | SEC ↗ | |
| Director | Purchase | 10,000 | $12K | Mar 9 | SEC ↗ | |
Ellis SeanFirst filing | Director | Purchase | 18,000 | $22K | Feb 11 | SEC ↗ |
Taitel HayaFirst filing | Director | Purchase | 7,500 | $11K | Feb 11 | SEC ↗ |
Germano Geno JFirst filing | Director | Purchase | 20,000 | $30K | Feb 11 | SEC ↗ |
Related companies
Entera Bio Ltd. is in the Healthcare sector.